Related to USC Researcher Gets $2.3M to Build Real-Time Nanolaser DNA Imaging Tool

• GSK to Exploit SuperGen’s Epigenetics Expertise in Cancer Collaboration
  
• Scripps-Led Consortium that Combines Physics and Oncology Receives $10M
  
• University of Florida Receives $15M, and Berkeley Lab Obtains $12.8M in ARRA Funding
  
• Horizon and University of Torino Win $500K Grant to Develop SNP-Based Cancer Models
  
• Ghent University to Leverage Roche´s LightCycler® 1536 Instrument for Cancer Research
  
• BioMarker Strategies Receives $1M Tranche of SBIR Funding to Develop Solid Tumor Biomarker Platform
  
• TauRx and Bayer Schering Pharma Pool Expertise to Develop Alzheimer Disease Diagnostics
  
• Lonza Negotiates License to Axxam’s Photoproteins for Clonetics Primary Sensor Cells
  
• Bind Biosciences Scores $12.4M to Progress Anticancer Nanotherapeutic
  
• Exact Sciences Obtains OncoMethylome Biomarkers for Colorectal Cancer Test
  
• PerkinElmer to Purchase VisEn for In Vivo Molecular Imaging Capabilities
  
• $6.3M DARPA Grant Allows GE to Assemble Team to Advance Nanosensor Technology
  
• Scientists Develop Dissolving Adjuvant Backpacks for Cell Therapy
  
• NHGRI Fortifies Third-Generation Sequencing Development with $18M
  
• New England Biolabs Receives $1.22M to Develop Enzymatic Reagents for Epigenetic Studies
  
• Caliper’s microCT Imaging Device to Be Used in NCI’s Preclinical Lung Cancer Studies
  
• Qualifying Therapeutic Discovery Project Doles Out More Than $17M
  
• Lilly Buys Avid for $300M for Phase III Amyloid Plaque Imaging Agent
  
• CVAF Pledges $1.5M for Clinical Development of Tolerx’ TRX518 Cancer mAb
  
• Cancer Targeted Technology to Help Bayer with Cancer PET Imaging Agent